Theravance Biopharma, Inc. (TBPH) Gross profit 2016–2017
Theravance Biopharma, Inc. (TBPH) annual gross profit history from SEC filings — each fiscal year as reported.
$9.4MFY2017 · since FY2016: $45.8M → $9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | $9.4M | -79.6% |
| FY2016 | $45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice